SMS Pharmaceuticals Ltd. - Research Center
532815 SMSPHARMA Group (B) BSE data
Results
Statement
More
| Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
Share application money
Preference share capital
Reserves & surplus
| 486.63 |
485.30 |
419.76 |
358.96 |
331.46 |
Secured loans
| 252.51 |
260.11 |
218.69 |
129.38 |
129.77 |
Unsecured loans
Total
| 747.61 |
753.87 |
646.92 |
496.80 |
469.69 |
Gross block
| 566.20 |
568.56 |
556.53 |
358.94 |
339.05 |
Less : revaluation reserve
Less : accumulated depreciation
| 154.18 |
130.57 |
99.17 |
78.45 |
57.79 |
Net block
| 412.02 |
437.99 |
457.36 |
280.49 |
281.26 |
Capital work-in-progress
| 33.19 |
11.00 |
6.74 |
42.12 |
18.30 |
Investments
| 45.10 |
45.00 |
45.00 |
45.00 |
45.00 |
Current assets, loans & advances
| 423.88 |
388.98 |
320.80 |
259.50 |
232.26 |
Less : current liabilities & provisions
| 166.57 |
129.10 |
182.99 |
130.30 |
107.13 |
Total net current assets
| 257.31 |
259.88 |
137.81 |
129.19 |
125.14 |
Miscellaneous expenses not written
Total
| 747.61 |
753.87 |
646.92 |
496.80 |
469.69 |
Book value of unquoted investments
| 45.10 |
45.00 |
45.00 |
45.00 |
45.00 |
Market value of quoted investments
Contingent liabilities
| 132.30 |
138.21 |
65.97 |
159.50 |
112.36 |
Number of equity sharesoutstanding (Lacs)
| 846.52 |
846.52 |
846.52 |
846.52 |
846.52 |